SCHEMBL8869604

SCHEMBL8869604

COCCNC(=O)c1ccc(C(=O)NS(=O)(=O)c2ccc(C(=O)NCCc3ccc(Cl)cc3)cc2)cn1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.53
PPARA Q07869 2/20 0.52
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
P4HTM Q9NXG6 1/20 0.49
FLT1 P17948 1/20 0.49
FLT4 P35916 1/20 0.49
KDR P35968 1/20 0.49
NAMPT P43490 1/20 0.49
NLRP3 Q96P20 1/20 0.48
GAA P10253 3/20 0.47
MAPT P10636 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C19 P33261 1/20 0.47
GFER P55789 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
BCL2L1 Q07817 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869577 1.00 EGFR (0.53) EGFRPPARANPC1RAB9AMEN1
SCHEMBL8868425 0.93 P4HTM (0.53) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8870517 0.92 PPARA (0.50) EGFRPPARANPC1RAB9AMEN1
SCHEMBL8869128 0.92 PPARA (0.50) EGFRPPARANPC1RAB9AMEN1
SCHEMBL8868306 0.92 MAPT (0.53) NPC1RAB9AMEN1KMT2AP4HTM
SCHEMBL8868352 0.92 P4HTM (0.61) PPARANPC1RAB9AMEN1KMT2A
SCHEMBL8869630 0.92 MAPT (0.53) NPC1RAB9AMEN1KMT2AP4HTM
SCHEMBL9137994 0.91 EGFR (0.54) EGFRPPARANPC1RAB9AMEN1
SCHEMBL9139838 0.91 EGFR (0.54) EGFRPPARANPC1RAB9AMEN1
SCHEMBL8869066 0.91 PPARA (0.53) EGFRPPARANPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed